AKT1 E17K Inhibits Cancer Cell Migration by Abrogating β-Catenin Signaling
Sizhi Paul Gao(Memorial Sloan Kettering Cancer Center), David B. Solit(Memorial Sloan Kettering Cancer Center)
Cited by 20
Related Papers
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
|Nature|2012|1.7k
RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E)
|Nature|2011|1.4k
BRAF mutation predicts sensitivity to MEK inhibition
|Nature|2005|1.3k